text.skipToContent text.skipToNavigation

This site is optimized for Chrome, Edge, Firefox, and Safari. You may not have the best user experience in your current browser.

Thrombix® Topical Hemostat
Item3101
UOM BX
Packaging 25 / BX

Product review summary

Representative image. Actual product may vary.

View All Additional Items
Dressing Type
Please see the Instructions for Use for a complete listing of the indications, contraindications, warnings, and precautions.

Thrombix® Topical Hemostat

The Thrombix® topical hemostat is applied topically as an adjunct to manual compression and is indicated for the control of surface bleeding from vascular access sites and percutaneous catheters or tubes. 

WARNING: SEVERE BLEEDING AND THROMBOSIS COMPLICATIONS
- THROMBIN-JMI® can cause fatal severe bleeding or thrombosis. Thrombosis may result from the development of antibodies against bovine thrombin. Bleeding may result from the development of antibodies against factor V. These may cross-react with human factor V and lead to its deficiency.
- Do not re-expose patients to THROMBIN-JMI® if there are known or suspected antibodies to bovine thrombin and/or factor V.
- Monitor patients for abnormal coagulation laboratory values, bleeding, or thrombosis.

MC-007697 - Rev 1. Revised: 03/2022.

Thrombix® Topical Hemostat*
Item NumberDescription
3100Thrombix® Silver Topical Hemostat
3101Thrombix® Topical Hemostat